Autoimmunity and susceptibility to Hodgkin lymphoma: A population-based case-control study in Scandinavia

Journal of the National Cancer Institute

Volumn 98, Issue 18, 2006, Pages 1321-1330

  Landgren, Ola ^a   Engels, Eric A ^a   Pfeiffer, Ruth M ^a   Gridley, Gloria ^a   Mellemkjaer, Lene ^b   Olsen, Jørgen H ^b   Kerstann, Kimberly F ^a   Wheeler, William ^c   Hemminki, Kari ^d,e   Linet, Martha S ^a   Goldin, Lynn R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HODGKIN DISEASE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCANDINAVIA; STATISTICAL SIGNIFICANCE; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; CASE CONTROL STUDY; DISEASE PREDISPOSITION; IMMUNOLOGY; MIDDLE AGED; REGISTER; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; DENMARK; DISEASE SUSCEPTIBILITY; FEMALE; HODGKIN DISEASE; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; ODDS RATIO; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SARCOIDOSIS; SWEDEN;

EID: 33749002249     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj361     Document Type: Article

References (67)

1. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda MD: National Cancer Institute; 2006.
2. Hjalgrim H, Askling J, Rostgaard K, Hamilton-Dutoit S, Frisch M, Zhang JS, et al. Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 2003;349:1324-32.
3. Evans AS, Gutensohn NM. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer 1984;34:149-57.
4. Axdorph U, Porwit-MacDonald A, Sjoberg J, Grimfors G, Ekman M, Wang W, et al. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer 1999;81:1182-7.
5. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966; 26:1189-201.
6. Grufferman S, Cole P, Smith PG, Lukes RJ. Hodgkin's disease in siblings. N Engl J Med 1977;296:248-50.
7. Haim N, Cohen Y, Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer 1982;49:2197-200.
8. Kerzin-Storrar L, Faed MJ, MacGillivray JB, Smith PG. Incidence of familial Hodgkin's disease. Br J Cancer 1983;47:707-12.
9. Mack TM, Cozen W, Shibata DK, Weiss LM, Nathwani BN, Hernandez AM, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995;332:413-8.
10. Bernard SM, Cartwright RA, Darwin CM, Richards ID, Roberts B, O'Brien C, et al. Hodgkin's disease: Case control epidemiological study in Yorkshire. Br J Cancer 1987;55:85-90.
11. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
12. Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: A population-based study of 31 million person-years. Int J Cancer 1997;72:977-81.
13. Paltiel O, Schmit T, Adler B, Rachmilevitz EA, Polliack A, Cohen A, et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma: Results and limitations of a registry-linked study. Cancer 2000;88:2357-66.
14. Shugart YY, Hemminki K, Vaittinen P, Kingman A, Dong C. A genetic study of Hodgkin's lymphoma: An estimate of heritability and anticipation based on the familial cancer database in Sweden. Hum Genet 2000;106: 553-6.
15. Lindelof B, Eklund G. Analysis of hereditary component of cancer by use of a familial index by site. Lancet 2001;358:1696-8.
16. Hemminki K, Li X, Czene K. Familial risk of cancer: Data for clinical counseling and cancer genetics. Int J Cancer 2004;108:109-14.
17. Goldin LR, Pfeiffer RM, Gridley G, Gail MH, Li X, Mellemkjaer L, et al. Familial aggregation of Hodgkin lymphoma and related tumors. Cancer 2004;100:1902-8.
18. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285:1736-45.
19. Blerman PJ, Vose JM, Langnas AN, Ritkin RM, Hauke RJ, Smir BN, et al. Hodgkin's disease following solid organ transplantation. Ann Oncol 1996;7:265-70.
20. Klippel JH. Primer on the rheumatic diseases. 12th ed. Atlanta (GA): Arthritis Foundation; 2001.
21. Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002;31:66-71.
22. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et at. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
23. Isomaki HA, Hakulinen T, Joutsenlahti U. Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis 1978;31:691-6.
24. Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH. Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:761-8.
25. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993;85:307-11.
26. Ekstrom K, Hjalgrim H, Brandt L, Baecklund E, Klareskog L, Ekbom A, et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum 2003;48:963-70.
27. Thomas E, Brewster DH, Black RJ, Macfarlane GJ. Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000;88: 497-502.
28. Mellemkjaer L, Alexander F, Olsen JH. Cancer among children of parents with autoimmune diseases. Br J Cancer 2000;82:1353-7.
29. Hartge P, Wang SS, editors. Overview of the etiology and epidemiology of lymphoma. Philadelphia PA: Lippincott Williams & Wilkins; 2004.
30. Landgren O, Kerstann KF, Gridley G, Mellemkjaer L, Hemminki K, Linet MS, et al. Re: Familial clustering of Hodgkin lymphoma and multiple sclerosis. J Natl Cancer Inst 2005;97:543-4.
31. Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006;98: 51-60.
32. Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S, et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: A case-control study. Am J Epidemiol 2005;162:1153-61.
33. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: A meta-analysis. Arch Intern Med 2005;165:2337-44.
34. Landgren O, Bjorkholm M, Montgomery SM, Hjalgrim H, Sjoberg J, Goldin LR, et al. Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma. Int J Cancer 2006;118:449-52.
35. Witte JS, Greenland S, Kim LL, Arab L. Multilevel modeling in epidemiology with GLIMMIX. Epidemiology 2000;11:684-8.
36. Anonymous. Patientregistret 1987-1996: Kvalitet och innehåll (Swedish). Stockholm (Sweden): EpC, National Board of Health and Welfare; 1998.
37. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
38. Skarle A. Flergenerationsregistret. Stockholm (Sweden): Statistics Sweden, Population Statistics; 2001.
39. Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nation-wide Swedish family-cancer database - updated structure and familial rates. Acta Oncol 2001;40:772-7.
40. Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol 1998;15:225-36.
41. Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: Results from the Swedish Family-Cancer Database. Blood 2004;104: 1850-4.
42. Landgren O, Linet MS, McMaster ML, Gridley G, Hemminki K, Goldin LR. Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: A population-based case-control study. Int J Cancer 2006;118:3095-8.
43. Landgren O, Engels EA, Caporaso NE, Gridley G, Mellemkjaer L, Hemminki K, et al. Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood 2006;108:292-6.
44. Landgren O, Algernon C, Axdorph U, Nilsson B, Wedelin C, Porwit-MacDonald A, et al. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis. Haematologica 2003;88:438-44.
45. Herbertson R, Hancock BW. Hodgkin lymphoma in adolescents. Cancer Treat Rev 2005;31:339-60.
46. Thomas RK, Re D, Zander T, Wolf J, Diehl V. Epidemiology and etiology of Hodgkin's lymphoma. Ann Oncol 2002;13(Suppl 4):147-52.
47. De Roos AJ, Poole C, Teschke K, Olshan AF. An application of hierarchical regression in the investigation of multiple paternal occupational exposures and neuroblastoma in offspring. Am J Ind Med 2001;39:477-86.
48. George JN. Idiopathic thrombocytopenic purpua: Current issues for pathogenesis, diagnosis, and management in children and adults. Curr Hematol Rep 2003;2:381-7.
49. Epperly TD, Moore KE, Harrover JD. Polymyalgia rheumatica and temporal arthritis. Am Fam Physician 2000;62:789-96, 801.
50. Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996;32A:1753-7.
51. Hakulinen T, Isomaki H, Knekt P. Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med 1985;78: 29-32.
52. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 2002;99:3909-15.
53. Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, et al. Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1414-20.
54. Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. Lupus 2001;10:394-400.
55. Bernatsky S, Ramsey-Goldman R, Rajan R, Boivin JF, Joseph L, Lachance S, et al. Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis 2005;64:1507-9.
56. Seersholm N, Vestbo J, Viskum K. Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997;52:892-4.
57. Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999;160 (Pt 1):1668-72.
58. de Hemricourt E, De Boeck K, Hilte F, Abib A, Kockx M, Vandevivere J, et al. Sarcoidosis and sarcoid-like reaction following Hodgkin's disease. Report of two cases. Mol Imaging Biol 2003;5:15-9.
59. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361: 1111-8.
60. Mitchell DN, Rees RJ. A transmissible agent from sarcoid tissue. Lancet 1969;2:81-4.
61. Hiraga Y. An epidemiological study of clustering of sarcoidosis cases. Nippon Rinsho 1994;52:1438-42.
62. Panayeas S, Theodorakopoulos P, Bouras A, Constantopoulos S. Seasonal occurrence of sarcoidosis in Greece. Lancet 1991;338:510-1.
63. Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J Jr, Chase GA, et al. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol 2001;153:188-93.
64. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003;124:521-36.
65. Chang ET, Zheng T, Weir EG, Borowitz M, Mann RB, Spiegelman D, et al. Childhood social environment and Hodgkin's lymphoma: New findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2004;13:1361-70.
66. Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: The role of environmental factors. Autoimmun Rev 2004;3:394-400.
67. Martinelli G, Zinzani PL, Magagnoli M, Vianelli N, Tura S. Incidence and prognostic significance of idiopathic thrombocytopenic purpura in patients with Hodgkin's disease in complete hematological remission. Haematologica 1998;83:669-70.